AAAAAA
Results: 1-25/146
Authors:
Huitema, ADR
Mathot, RAA
Tibben, MM
Rodenhuis, S
Beijnen, JH
Citation: Adr. Huitema et al., A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide, J PHARMA PH, 28(3), 2001, pp. 211-230
Authors:
Veldkamp, AI
van Heeswijk, RPG
Mulder, JW
Meenhorst, PL
Schreij, G
van der Geest, S
Lange, JMA
Beijnen, JH
Hoetelmans, RMW
Citation: Ai. Veldkamp et al., Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals, J ACQ IMM D, 27(4), 2001, pp. 344-349
Authors:
Schoemaker, NE
Frigerio, E
Fraier, D
Schellens, JHM
Rosing, H
Jansen, S
Beijnen, JH
Citation: Ne. Schoemaker et al., High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma, J CHROMAT B, 763(1-2), 2001, pp. 173-183
Authors:
Bardelmeijer, HA
Ouwehand, M
Beijnen, JH
Schellens, JHM
van Tellingen, O
Citation: Ha. Bardelmeijer et al., Determination of cyclosporin A in human and mouse plasma by reversed-phasehigh-performance liquid chromatography, J CHROMAT B, 763(1-2), 2001, pp. 201-206
Authors:
Kemper, EM
Jansen, B
Brouwer, KR
Schellens, JHM
Beijnen, JH
van Tellingen, O
Citation: Em. Kemper et al., Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection, J CHROMAT B, 759(1), 2001, pp. 135-143
Authors:
Huitema, ADR
Reinders, C
Tibben, MM
Rodenhuis, S
Beijnen, JH
Citation: Adr. Huitema et al., Sensitive gas chromatographic determination of the cyclophosphamide metabolite 2-dechloroethylcyclophosphamide in human plasma, J CHROMAT B, 757(2), 2001, pp. 349-357
Authors:
Waterval, JCM
Bloks, JC
Sparidans, RW
Beijnen, JH
Rodriguez-Campos, IM
Bult, A
Lingeman, H
Underberg, WJM
Citation: Jcm. Waterval et al., Degradation kinetics of aplidine, a new marine antitumoural cyclic peptide, in aqueous solution, J CHROMAT B, 754(1), 2001, pp. 161-168
Authors:
Sparidans, RW
Hoetelmans, RMW
Beijnen, JH
Citation: Rw. Sparidans et al., Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection, J CHROMAT B, 750(1), 2001, pp. 155-161
Authors:
Malingre, MM
Rosing, H
Koopman, FJ
Schellens, JHM
Beijnen, JH
Citation: Mm. Malingre et al., Performance of the analytical assays of paclitaxel, docetaxel, and cyclosporin a in a routine hospital laboratory setting, J LIQ CHR R, 24(17), 2001, pp. 2697-2717
Authors:
Maliepaard, M
van Gastelen, MA
Tohgo, A
Hausheer, FH
van Waardenburg, RCAM
de Jong, LA
Pluim, D
Beijnen, JH
Schellens, JHM
Citation: M. Maliepaard et al., Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918, CLIN CANC R, 7(4), 2001, pp. 935-941
Authors:
Witkamp, AJ
de Bree, E
Kaag, MM
Boot, H
Beijnen, JH
van Slooten, GW
van Coevorden, F
Zoetmulder, FAN
Citation: Aj. Witkamp et al., Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin, EUR J CANC, 37(8), 2001, pp. 979-984
Authors:
Sparidans, RW
Rosing, H
Hillebrand, MJX
Lopez-Lazaro, L
Jimeno, JM
Manzanares, I
van Kesteren, C
Cvitkovic, E
van Oosterom, AT
Schellens, JHM
Beijnen, JH
Citation: Rw. Sparidans et al., Search for metabolites of ecteinascidin 743, a novel, marine-derived, anti-cancer agent, in man, ANTI-CANC D, 12(8), 2001, pp. 653-666
Authors:
Sparidans, RW
Stokvis, E
Jimeno, JM
Lopez-Lazaro, L
Schellens, JHM
Beijnen, JH
Citation: Rw. Sparidans et al., Chemical and enzymatic stability of a cyclic depsipeptide, the novel, marine-derived, anti-cancer agent kahalalide F, ANTI-CANC D, 12(7), 2001, pp. 575-582
Authors:
Malingre, MM
Huinink, WWT
Duchin, K
Schellens, JHM
Beijnen, JH
Citation: Mm. Malingre et al., Pharmacokinetics of oral cyclosporin A when co-administered to enhance theoral absorption of paclitaxel, ANTI-CANC D, 12(7), 2001, pp. 591-593
Authors:
van Maanen, MJ
Huitema, ADR
Rodenhuis, S
Beijnen, JH
Citation: Mj. Van Maanen et al., Urinary excretion of thioTEPA and its metabolites in patients treated withhigh-dose cyclophosphamide, thioTEPA and carboplatin, ANTI-CANC D, 12(6), 2001, pp. 519-524
Authors:
Terwogt, JMM
Huinink, WWT
Schellens, JHM
Schot, M
Mandjes, IAM
Zurlo, MG
Rocchetti, M
Rosing, H
Koopman, FJ
Beijnen, JH
Citation: Jmm. Terwogt et al., Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 315-323
Authors:
Malingre, MM
Beijnen, JH
Rosing, H
Koopman, FJ
van Tellingen, O
Duchin, K
Huinink, WWT
Swart, M
Lieverst, J
Schellens, JHM
Citation: Mm. Malingre et al., The effect of different doses of cyclosporin A on the systemic exposure oforally administered paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 351-358
Authors:
Crul, M
de Klerk, GJ
Beijnen, JH
Schellens, JHM
Citation: M. Crul et al., Ras biochemistry and farnesyl transferase inhibitors: a literature survey, ANTI-CANC D, 12(3), 2001, pp. 163-184
Authors:
Crul, M
van den Bongard, HJGD
Tibben, MM
van Tellingen, O
Sava, G
Schellens, JHM
Beijnen, JH
Citation: M. Crul et al., Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry, FRESEN J AN, 369(5), 2001, pp. 442-445
Authors:
van Putten, JWG
Kerbush, T
Smit, EF
van Rijswijk, R
Beijnen, JH
Sleijfer, DT
Groen, HJM
Citation: Jwg. Van Putten et al., Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer, ANN ONCOL, 12(6), 2001, pp. 787-792
Authors:
Malingre, MM
Richel, DJ
Beijnen, JH
Rosing, H
Koopman, FJ
Huinink, WWTB
Schot, ME
Schellens, JHM
Citation: Mm. Malingre et al., Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel, J CL ONCOL, 19(4), 2001, pp. 1160-1166
Authors:
Nuijen, B
Bouma, M
Talsma, H
Manada, C
Jimeno, JM
Lopez-Lazaro, L
Bult, A
Beijnen, JH
Citation: B. Nuijen et al., Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F, DRUG DEV IN, 27(8), 2001, pp. 767-780
Authors:
Kerbusch, T
vanPutten, JWG
Groen, HJM
Huitema, ADR
Mathot, RAA
Beijnen, JH
Citation: T. Kerbusch et al., Population pharmacokinetics of ifosfamide and its 2-and 3-dechloroethylated and 4-hydroxylated metabolites in resistant small-cell lung cancer patients, CANC CHEMOT, 48(1), 2001, pp. 53-61
Authors:
van den Bongard, HJGD
Mathot, RAA
Boogerd, W
Schornagel, JH
Soesan, M
Schellens, JHM
Beijnen, JH
Citation: Hjgd. Van Den Bongard et al., Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure, CANC CHEMOT, 47(6), 2001, pp. 537-540
Authors:
Malingre, MM
Beijnen, JH
Rosing, H
Koopman, FJ
van Tellingen, O
Duchin, K
Huinink, WWT
Swart, M
Lieverst, J
Schellens, JHM
Citation: Mm. Malingre et al., A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A, CANC CHEMOT, 47(4), 2001, pp. 347-354